Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 3Lymphoid 3Classical hematology 3Sarcoma 1Plasma cell 1

Conditions

Sarcoma 210Bone Neoplasms 58Neoplasms 39Breast Neoplasms 39Osteosarcoma 37Lymphoma 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Gastrointestinal Stromal Tumors 31Dendritic Cell Sarcoma, Interdigitating 31Hodgkin Disease 29Lymphoma, Non-Hodgkin 27Leukemia 27Burkitt Lymphoma 25Melanoma 24Brain Neoplasms 24Multiple Myeloma 23Leukemia, Myeloid, Acute 23Sarcoma, Ewing 22Recurrence 21Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Glioblastoma 21Neuroblastoma 20Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma, Large-Cell, Immunoblastic 18Gliosarcoma 18Sarcoma, Kaposi 17Prostatic Neoplasms 17Pancreatic Neoplasms 17

Interventions

fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Bone Marrow Failure Disorders × Sarcoma × Clear all
NCT02145039 2019-12-26

Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
2 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡